Advertisement
Research Article

Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction

  • Verena Paulitschke,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Silke Gruber,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Elisabeth Hofstätter,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Verena Haudek-Prinz,

    Affiliation: Department of Medicine I, Medical University of Vienna, Vienna, Austria

    X
  • Philipp Klepeisz,

    Affiliation: Department of Medicine I, Medical University of Vienna, Vienna, Austria

    X
  • Nikolaus Schicher,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Constanze Jonak,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Peter Petzelbauer,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Hubert Pehamberger,

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Christopher Gerner,

    Affiliation: Department of Medicine I, Medical University of Vienna, Vienna, Austria

    X
  • Rainer Kunstfeld mail

    rainer.kunstfeld@meduniwien.ac.at

    Affiliation: Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Published: September 25, 2012
  • DOI: 10.1371/journal.pone.0046103

Reader Comments (0)

Post a new comment on this article